Kuei-Hua Chang
Affiliations: | 2012 | Purdue University, West Lafayette, IN, United States |
Google:
"Kuei-Hua Chang"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Chang KH, Vincent F, Shah K. (2012) Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death. Journal of Cell Science. 125: 5124-37 |
Johnson EO, Chang KH, Ghosh S, et al. (2012) LIMK2 is a crucial regulator and effector of Aurora-A-kinase-mediated malignancy. Journal of Cell Science. 125: 1204-16 |
Chi X, Amet T, Byrd D, et al. (2011) Direct effects of HIV-1 Tat on excitability and survival of primary dorsal root ganglion neurons: possible contribution to HIV-1-associated pain. Plos One. 6: e24412 |
Kumar D, Kumar NM, Chang KH, et al. (2011) Synthesis and in-vitro anticancer activity of 3,5-bis(indolyl)-1,2,4-thiadiazoles. Bioorganic & Medicinal Chemistry Letters. 21: 5897-900 |
Johnson EO, Chang KH, de Pablo Y, et al. (2011) PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer. Journal of Cell Science. 124: 2711-22 |
Sun KH, Chang KH, Clawson S, et al. (2011) Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity. Journal of Neurochemistry. 118: 902-14 |
Kumar D, Patel G, Chavers AK, et al. (2011) Synthesis of novel 1,2,4-oxadiazoles and analogues as potential anticancer agents. European Journal of Medicinal Chemistry. 46: 3085-92 |
Kumar D, Vaddula BR, Chang KH, et al. (2011) One-pot synthesis and anticancer studies of 2-arylamino-5-aryl-1,3,4-thiadiazoles. Bioorganic & Medicinal Chemistry Letters. 21: 2320-3 |
Chang KH, Multani PS, Sun KH, et al. (2011) Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death. Molecular Biology of the Cell. 22: 1452-62 |
Kumar D, Narayanam MK, Chang KH, et al. (2011) Synthesis of novel indolyl-1,2,4-triazoles as potent and selective anticancer agents. Chemical Biology & Drug Design. 77: 182-8 |